Cargando…

The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial

BACKGROUND: The care needs of patients with a limited prognosis (<12 months median) are complex and dynamic. Patients and caregivers must cope with many challenges, including physical symptoms and disabilities, uncertainty. and compromised self-efficacy. Healthcare is often characterized by disru...

Descripción completa

Detalles Bibliográficos
Autores principales: Siegle, Anja, Villalobos, Matthias, Bossert, Jasmin, Krug, Katja, Hagelskamp, Laura, Krisam, Johannes, Handtke, Violet, Deis, Nicole, Jünger, Jana, Wensing, Michel, Thomas, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092809/
https://www.ncbi.nlm.nih.gov/pubmed/30107809
http://dx.doi.org/10.1186/s13063-018-2814-1
_version_ 1783347595429543936
author Siegle, Anja
Villalobos, Matthias
Bossert, Jasmin
Krug, Katja
Hagelskamp, Laura
Krisam, Johannes
Handtke, Violet
Deis, Nicole
Jünger, Jana
Wensing, Michel
Thomas, Michael
author_facet Siegle, Anja
Villalobos, Matthias
Bossert, Jasmin
Krug, Katja
Hagelskamp, Laura
Krisam, Johannes
Handtke, Violet
Deis, Nicole
Jünger, Jana
Wensing, Michel
Thomas, Michael
author_sort Siegle, Anja
collection PubMed
description BACKGROUND: The care needs of patients with a limited prognosis (<12 months median) are complex and dynamic. Patients and caregivers must cope with many challenges, including physical symptoms and disabilities, uncertainty. and compromised self-efficacy. Healthcare is often characterized by disruptions in the transition between healthcare providers. The Milestones Communication Approach (MCA) is a structured, proactive, interprofessional concept that involves physicians and nurses and is aimed at providing coherent care across the disease trajectory. This study aims to evaluate these aspects of MCA: (1) the training of healthcare professionals, (2) implementation context and outcomes, (3) patient outcomes, and (4) effects on interprofessional collaboration. METHODS/DESIGN: A multiphase mixed-methods design will be used for the study. A total of 100 patients and 120 healthcare professionals in a specialized oncology hospital will be involved. The training outcomes will be documented using a questionnaire. Implementation context and outcomes will be explored through semi-structured interviews and written questionnaires with healthcare professionals and with the training participants and through a content analysis of patient files. Patient outcomes will be assessed in a pragmatic non-blinded randomized controlled trial and in qualitative interviews with patients and caregivers. Trial outcomes are supportive care needs (SCNS-SF34-G), quality of life (SeiQol and Fact-L), depression and anxiety symptoms (PHQ-4), and distress (Distress Thermometer). Qualitative semi-structured interviews on patients’ views will focus on shared decision-making, communication needs, feeling empathy, and further utilization of healthcare services. Interprofessional collaboration will be explored using the UWE-IP-D before the implementation of MCA (t0) and after 3 (t1), 9 (t2), and 12 (t3) months. DISCUSSION: Using guideline-concordant early palliative care, MCA aims to foster patient-centered communication with shared decision-making and facilitation of advance care planning including end-of-life decisions, thus increasing patient quality of life and decreasing aggressive medical care at the end of life. It is assumed that the communication skills training and interprofessional coaching will improve the communication behavior of healthcare providers and influence team communications and team processes. TRIAL REGISTRATION: German Clinical Trials Register, DRKS00013649 and DRKS00013469. Registered on 22 December 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13063-018-2814-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6092809
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60928092018-08-20 The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial Siegle, Anja Villalobos, Matthias Bossert, Jasmin Krug, Katja Hagelskamp, Laura Krisam, Johannes Handtke, Violet Deis, Nicole Jünger, Jana Wensing, Michel Thomas, Michael Trials Study Protocol BACKGROUND: The care needs of patients with a limited prognosis (<12 months median) are complex and dynamic. Patients and caregivers must cope with many challenges, including physical symptoms and disabilities, uncertainty. and compromised self-efficacy. Healthcare is often characterized by disruptions in the transition between healthcare providers. The Milestones Communication Approach (MCA) is a structured, proactive, interprofessional concept that involves physicians and nurses and is aimed at providing coherent care across the disease trajectory. This study aims to evaluate these aspects of MCA: (1) the training of healthcare professionals, (2) implementation context and outcomes, (3) patient outcomes, and (4) effects on interprofessional collaboration. METHODS/DESIGN: A multiphase mixed-methods design will be used for the study. A total of 100 patients and 120 healthcare professionals in a specialized oncology hospital will be involved. The training outcomes will be documented using a questionnaire. Implementation context and outcomes will be explored through semi-structured interviews and written questionnaires with healthcare professionals and with the training participants and through a content analysis of patient files. Patient outcomes will be assessed in a pragmatic non-blinded randomized controlled trial and in qualitative interviews with patients and caregivers. Trial outcomes are supportive care needs (SCNS-SF34-G), quality of life (SeiQol and Fact-L), depression and anxiety symptoms (PHQ-4), and distress (Distress Thermometer). Qualitative semi-structured interviews on patients’ views will focus on shared decision-making, communication needs, feeling empathy, and further utilization of healthcare services. Interprofessional collaboration will be explored using the UWE-IP-D before the implementation of MCA (t0) and after 3 (t1), 9 (t2), and 12 (t3) months. DISCUSSION: Using guideline-concordant early palliative care, MCA aims to foster patient-centered communication with shared decision-making and facilitation of advance care planning including end-of-life decisions, thus increasing patient quality of life and decreasing aggressive medical care at the end of life. It is assumed that the communication skills training and interprofessional coaching will improve the communication behavior of healthcare providers and influence team communications and team processes. TRIAL REGISTRATION: German Clinical Trials Register, DRKS00013649 and DRKS00013469. Registered on 22 December 2017. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13063-018-2814-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-08-14 /pmc/articles/PMC6092809/ /pubmed/30107809 http://dx.doi.org/10.1186/s13063-018-2814-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Siegle, Anja
Villalobos, Matthias
Bossert, Jasmin
Krug, Katja
Hagelskamp, Laura
Krisam, Johannes
Handtke, Violet
Deis, Nicole
Jünger, Jana
Wensing, Michel
Thomas, Michael
The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial
title The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial
title_full The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial
title_fullStr The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial
title_full_unstemmed The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial
title_short The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial
title_sort heidelberg milestones communication approach (mca) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092809/
https://www.ncbi.nlm.nih.gov/pubmed/30107809
http://dx.doi.org/10.1186/s13063-018-2814-1
work_keys_str_mv AT siegleanja theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT villalobosmatthias theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT bossertjasmin theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT krugkatja theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT hagelskamplaura theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT krisamjohannes theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT handtkeviolet theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT deisnicole theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT jungerjana theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT wensingmichel theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT thomasmichael theheidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT siegleanja heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT villalobosmatthias heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT bossertjasmin heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT krugkatja heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT hagelskamplaura heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT krisamjohannes heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT handtkeviolet heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT deisnicole heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT jungerjana heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT wensingmichel heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial
AT thomasmichael heidelbergmilestonescommunicationapproachmcaforpatientswithprognosis12monthsprotocolforamixedmethodsstudyincludingarandomizedcontrolledtrial